Introduction:
In the heart of India’s innovation hub, Bengaluru, a dynamic startup is revolutionizing the wellness industry. Founded in 2023 by Karan Naidu and Praveen Singh Rajput, Calmosis merges ancient Ayurvedic wisdom with modern cannabis science to deliver natural solutions for stress, anxiety, pain, and sleep issues. As the first company to legally offer cannabis-based products in India, Calmosis is poised to transform how people manage their health and well-being.
The Catalyst for Change
Karan Naidu’s journey to founding Calmosis began with a personal challenge. His mother struggled with chronic sleep problems and relied on allopathic sleeping pills, which came with unwanted side effects. Witnessing her struggle firsthand, Karan was determined to find a better solution. His research led him to the healing potential of Ayurvedic herbs and medicinal cannabis, known as Vijaya in ancient texts. Driven by a mission to help others like his mother, Karan partnered with entrepreneur Praveen Singh Rajput to bring Calmosis to life.
Navigating Uncharted Territory
Launching Calmosis was no easy feat. Cannabis, though historically revered in India for its medicinal properties, had been illegal since 1985 due to its association with recreational use. However, regulatory changes in 2022 opened the door for medicinal cannabis under Ayurvedic doctor supervision. Karan and Praveen meticulously navigated the complex legal landscape, obtaining licenses from the Ayush Ministry of Madhya Pradesh to ethically source and manufacture their products. Their commitment to operating within legal frameworks sets Calmosis apart as a trusted and compliant cannabis wellness brand.
Crafting Nature’s Remedy
At the heart of Calmosis are its flagship products: Peace Mantra for stress relief and Sleep Mantra for restful slumber. Developed through extensive research and clinical testing, these elixirs harness the healing power of cannabis combined with Ayurvedic herbs. The Calmosis team works closely with Ayurvedic doctors and cannabis experts to perfect their formulations, ensuring optimal ratios of CBD, THC, and other beneficial cannabinoids. The result is a range of safe, effective, and non-addictive alternatives to pharmaceuticals, empowering people to reclaim their well-being naturally.
Sowing Seeds of Change
Beyond its products, Calmosis is cultivating a movement of plant-based healing. Through educational content and community outreach, the startup aims to destigmatize cannabis and raise awareness about its medicinal applications. Calmosis also prioritizes sustainability and social responsibility, ethically sourcing ingredients and adopting eco-friendly practices. Looking ahead, the company plans to expand its offerings to include solutions for menstrual pain and pet anxiety, bringing the benefits of Ayurvedic cannabis to even more individuals in need.
Timeline:
- 2022: Indian government relaxes cannabis laws for medicinal use under Ayurvedic supervision
- 2023: Karan Naidu and Praveen Singh Rajput found Calmosis in Bengaluru
- 2023: Calmosis obtains licenses from Ayush Ministry of Madhya Pradesh for cannabis manufacturing
- 2023: Peace Mantra and Sleep Mantra launched after clinical testing and AYUSH ministry approval
- 2024: Calmosis expands product line to include solutions for menstrual pain and pet anxiety
- 2024: Calmosis begins serving customers in the US, Europe, and Southeast Asia
Key Takeaways:
Calmosis exemplifies the power of merging ancient wisdom with modern innovation. By harnessing the medicinal properties of cannabis through an Ayurvedic lens, the startup is providing much-needed natural alternatives for stress, anxiety, pain, and sleep issues. Karan Naidu and Praveen Singh Rajput’s journey highlights the importance of perseverance, adaptability, and a commitment to operating ethically within evolving legal frameworks. As Calmosis continues to grow, it has the potential to reshape attitudes around cannabis and pave the way for a more holistic, plant-based approach to health and wellness in India and beyond.
